drugset
drugset / Trial / NCT03748212

Clinical Trial to Evaluate Pharmacokinetic Profiles and Safety Between CKD-385 and D935 in Healthy Volunteers

NCT03748212 ↗

Phase 1 Unknown 52 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open-label, fed, single dose, crossover study to evaluate the pharmacokinetic profiles and safety of CKD-385 in healthy volunteers

Timeline

Start
2018-10-24
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-385 Unknown — Oral
Comparator D935 Unknown — Oral

Indications

hypertensive disorder